Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a kidney transplant and are experiencing a significant drop in how well the transplanted kidney is filtering blood, where other causes such as rejection, blockage, or infection have been ruled out.
- People who had a transplanted kidney that was filtering blood at less than half the expected level within 30 days of the transplant, for unknown reasons.
- People whose kidney filtering ability dropped significantly after starting a certain type of blood pressure medication (ACE inhibitors or ARBs).
- People who have had persistently high blood pressure for more than 6 weeks after a kidney transplant, despite taking at least three different types of blood pressure medications at the highest doses they can tolerate.
- People whose imaging tests (CT scan or MRI) show a narrowing of 50% or more in the artery supplying the transplanted kidney.
- People whose ultrasound results show specific patterns of abnormal blood flow in the transplanted kidney's artery that suggest a significant narrowing (confirm with trial site).
- People where strong clinical concern exists about a blood vessel complication but scans cannot rule it out clearly — in these cases, further internal imaging tests may be used to confirm eligibility (confirm with trial site).
- People whose internal imaging during the procedure confirms a narrowing of 70% or more, or a narrowing of 50–69% alongside specific pressure measurements across the narrowed area that meet set thresholds (confirm with trial site).
Who may not be able to join:
- People who are not able to give informed consent to participate.
- People whose kidney biopsy shows rejection that requires active treatment.
- People who are pregnant.
- People who have already had a balloon procedure (PTA) on the same blood vessel being considered for treatment.
- People who cannot tolerate any blood-thinning medications, as this would make them ineligible for stent placement.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mark Reinhard, MD, PhD, Aarhus University Hospital
Phone: +45 40460321
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in measured glomerular filtration rate (mGFR).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.